Conserved Motifs within Hepatitis C Virus Envelope (E2) RNA and Protein Independently Inhibit T Cell Activation

PLoS Pathogens

Volumn 11, Issue 9, 2015, Pages

  Bhattarai, Nirjal ^a,b   McLinden, James H ^a,b   Xiang, Jinhua ^a,b   Kaufman, Thomas M ^a,b   Stapleton, Jack T ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E2; T LYMPHOCYTE RECEPTOR; GLYCOPROTEIN E2, HEPATITIS C VIRUS; LYMPHOCYTE ANTIGEN RECEPTOR; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ADAPTIVE IMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FLOW CYTOMETRY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE ACTIVATION; CONSERVED SEQUENCE; HEPACIVIRUS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VIRION;

BASE SEQUENCE; CONSERVED SEQUENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LYMPHOCYTE ACTIVATION; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; RNA, VIRAL; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS; VIRION;

EID: 84943516708     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005183     Document Type: Article

References (60)

1. Rehermann B, (2013) Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nat Med 19: 859–868. doi: 10.1038/nm.3251 23836236
2. Rehermann B, (2009) Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 119: 1745–1754. doi: 10.1172/JCI39133 19587449
3. Park SH, Veerapu NS, Shin EC, Biancotto A, McCoy JP, et al. (2013) Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med 19: 1638–1642. doi: 10.1038/nm.3408 24270546
4. Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, et al. (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169: 3447–3458. 12218168
5. Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, et al. (2001) Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 75: 5550–5558. 11356962
6. Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, et al. (2005) Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 42: 828–837. 16175596
7. Freeman AJ, Pan Y, Harvey CE, Post JJ, Law MG, et al. (2003) The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J Hepatol 38: 349–356. 12586302
8. Day CL, Seth NP, Lucas M, Appel H, Gauthier L, et al. (2003) Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest 112: 831–842. 12975468
9. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, et al. (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659–662. 14576438
10. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, et al. (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191: 1499–1512. 10790425
11. Bowen DG, Walker CM, (2005) Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436: 946–952. 16107834
12. Corell A, Morales JM, Mandrono A, Munoz MA, Andres A, et al. (1995) Immunosuppression induced by hepatitis C virus infection reduces acute renal-transplant rejection. Lancet 346: 1497–1498. 7491027
13. Moorman JP, Zhang CL, Ni L, Ma CJ, Zhang Y, et al. (2011) Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses. Vaccine 29: 3169–3176. doi: 10.1016/j.vaccine.2011.02.052 21376795
14. Shi L, Wang JM, Ren JP, Cheng YQ, Ying RS, et al. (2014) KLRG1 impairs CD4+ T cell responses via p16ink4a and p27kip1 pathways: role in hepatitis B vaccine failure in individuals with hepatitis C virus infection. J Immunol 192: 649–657. doi: 10.4049/jimmunol.1302069 24337749
15. Ramakrishnaiah V, Thumann C, Fofana I, Habersetzer F, Pan Q, et al. (2013) Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc Natl Acad Sci U S A 110: 13109–13113. doi: 10.1073/pnas.1221899110 23878230
16. Cosset FL, Dreux M, (2014) HCV transmission by hepatic exosomes establishes a productive infection. J Hepatol 60: 674–675. doi: 10.1016/j.jhep.2013.10.015 24512825
17. Masciopinto F, Giovani C, Campagnoli S, Galli-Stampino L, Colombatto P, et al. (2004) Association of hepatitis C virus envelope proteins with exosomes. Eur J Immunol 34: 2834–2842. 15368299
18. Bukong TN, Momen-Heravi F, Kodys K, Bala S, Szabo G, (2014) Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90. PLoS Pathog 10: e1004424. doi: 10.1371/journal.ppat.1004424 25275643
19. Dreux M, Garaigorta U, Boyd B, Decembre E, Chung J, et al. (2012) Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12: 558–570. doi: 10.1016/j.chom.2012.08.010 23084922
20. Tu Z, Zhang P, Li H, Niu J, Jin X, et al. (2013) Cross-linking of CD81 by HCV-E2 protein inhibits human intrahepatic plasmacytoid dendritic cells response to CpG-ODN. Cell Immunol 284: 98–103. doi: 10.1016/j.cellimm.2013.07.012 23954883
21. Schmidt WN, Wu P, Han JQ, Perino MJ, LaBrecque DR, et al. (1997) Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load. J Infect Dis 176: 20–26. 9207345
22. Wang JT, Sheu JC, Lin JT, Wang TH, Chen DS, (1992) Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis 166: 1167–1169. 1328405
23. Zignego AL, Giannini C, Monti M, Gragnani L, (2007) Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis 39 Suppl 1: S38–45. 17936221
24. Sarhan MA, Pham TN, Chen AY, Michalak TI, (2012) Hepatitis C virus infection of human T lymphocytes is mediated by CD5. J Virol 86: 3723–3735. doi: 10.1128/JVI.06956-11 22278227
25. Morsica G, Tambussi G, Sitia G, Novati R, Lazzarin A, et al. (1999) Replication of hepatitis C virus in B lymphocytes (CD19+). Blood 94: 1138–1139. 10454799
26. Blackard JT, Kemmer N, Sherman KE, (2006) Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44: 15–22. 16799966
27. Lerat H, Berby F, Trabaud MA, Vidalin O, Major M, et al. (1996) Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 97: 845–851. 8609243
28. Pham TN, King D, Macparland SA, McGrath JS, Reddy SB, et al. (2008) Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 134: 812–822. doi: 10.1053/j.gastro.2007.12.011 18243182
29. Medzhitov R, Janeway CA, Jr. (1998) Innate immune recognition and control of adaptive immune responses. Semin Immunol 10: 351–353. 9799709
30. Soderholm J, Sallberg M, (2006) A complete mutational fitness map of the hepatitis C virus nonstructural 3 protease: relation to recognition by cytotoxic T lymphocytes. J Infect Dis 194: 1724–1728. 17109345
31. Radziewicz H, Hanson HL, Ahmed R, Grakoui A, (2008) Unraveling the role of PD-1/PD-L interactions in persistent hepatotropic infections: potential for therapeutic application? Gastroenterology 134: 2168–2171. doi: 10.1053/j.gastro.2008.04.012 18486616
32. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, et al. (2012) MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A 109: E2110–2116. doi: 10.1073/pnas.1209414109 22753494
33. Davis SJ, van der Merwe PA, (2011) Lck and the nature of the T cell receptor trigger. Trends Immunol 32: 1–5. doi: 10.1016/j.it.2010.11.003 21190897
34. Xue Y, Ren J, Gao X, Jin C, Wen L, et al. (2008) GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Mol Cell Proteomics 7: 1598–1608. doi: 10.1074/mcp.M700574-MCP200 18463090
35. Bhattarai N, McLinden JH, Xiang J, Landay AL, Chivero ET, et al. (2013) GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling. J Immunol 190: 6351–6359. doi: 10.4049/jimmunol.1300589 23686495
36. Ahmed F, Kaundal R, Raghava GP, (2013) PHDcleav: a SVM based method for predicting human Dicer cleavage sites using sequence and secondary structure of miRNA precursors. BMC Bioinformatics 14 Suppl 14: S9. doi: 10.1186/1471-2105-14-S14-S9 24267009
37. Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, et al. (2012) Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci U S A 109: 941–946. doi: 10.1073/pnas.1112263109 22215596
38. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, et al. (2007) Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci U S A 104: 12884–12889. 17616579
39. Parameswaran P, Sklan E, Wilkins C, Burgon T, Samuel MA, et al. (2010) Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog 6: e1000764. doi: 10.1371/journal.ppat.1000764 20169186
40. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15–20. 15652477
41. Roskoski R, Jr. (2005) Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 331: 1–14. 15845350
42. Gil-Henn H, Elson A, (2003) Tyrosine phosphatase-epsilon activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells. J Biol Chem 278: 15579–15586. 12598528
43. Granot-Attas S, Luxenburg C, Finkelshtein E, Elson A, (2009) Protein tyrosine phosphatase epsilon regulates integrin-mediated podosome stability in osteoclasts by activating Src. Mol Biol Cell 20: 4324–4334. doi: 10.1091/mbc.E08-11-1158 19692574
44. Toledano-Katchalski H, Elson A, (1999) The transmembranal and cytoplasmic forms of protein tyrosine phosphatase epsilon physically associate with the adaptor molecule Grb2. Oncogene 18: 5024–5031. 10490839
45. Sharma S, Findlay GM, Bandukwala HS, Oberdoerffer S, Baust B, et al. (2011) Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc Natl Acad Sci U S A 108: 11381–11386. doi: 10.1073/pnas.1019711108 21709260
46. Nelson DR, Gonzalez-Peralta RP, Qian K, Xu Y, Marousis CG, et al. (1997) Transforming growth factor-beta 1 in chronic hepatitis C. J Viral Hepat 4: 29–35. 9031062
47. Reiser M, Marousis CG, Nelson DR, Lauer G, Gonzalez-Peralta RP, et al. (1997) Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol 26: 471–478. 9075651
48. Jang IK, Zhang J, Chiang YJ, Kole HK, Cronshaw DG, et al. (2010) Grb2 functions at the top of the T-cell antigen receptor-induced tyrosine kinase cascade to control thymic selection. Proc Natl Acad Sci U S A 107: 10620–10625. doi: 10.1073/pnas.0905039107 20498059
49. Supekova L, Supek F, Lee J, Chen S, Gray N, et al. (2008) Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. J Biol Chem 283: 29–36. 17951261
50. Schijman A, Colina R, Mukomolov S, Kalinina O, Garcia L, et al. (2004) Comparison of hepatitis C viral loads in patients with or without coinfection with different genotypes. Clin Diagn Lab Immunol 11: 433–435. 15014001
51. Matthews-Greer JM, Caldito GC, Adley SD, Willis R, Mire AC, et al. (2001) Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin Diagn Lab Immunol 8: 690–694. 11427412
52. Chivero ET, Bhattarai N, Rydze RT, Winters MA, Holodniy M, et al. (2014) Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro. J Gen Virol 95: 1307–1319. doi: 10.1099/vir.0.063016-0 24668525
53. Feng Z, Hensley L, McKnight KL, Hu F, Madden V, et al. (2013) A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 496: 367–371. doi: 10.1038/nature12029 23542590
54. Rios-Olivares E, Vila LM, Reyes JC, Rodriguez JW, Colon JH, et al. (2006) Impaired cytokine production and suppressed lymphocyte proliferation activity in HCV-infected cocaine and heroin ("speedball") users. Drug Alcohol Depend 85: 236–243. 16766138
55. Folgori A, Spada E, Pezzanera M, Ruggeri L, Mele A, et al. (2006) Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance. Gut 55: 1012–1019. 16484505
56. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, et al. (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110–113. 10390360
57. Quinkert D, Bartenschlager R, Lohmann V, (2005) Quantitative analysis of the hepatitis C virus replication complex. J Virol 79: 13594–13605. 16227280
58. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 623–626. 15947137
59. Mohr EL, Xiang J, McLinden JH, Kaufman TM, Chang Q, et al. (2010) GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates. J Immunol 185: 4496–4505. doi: 10.4049/jimmunol.1001980 20826757
60. Xiang J, McLinden JH, Kaufman TM, Mohr EL, Bhattarai N, et al. (2012) Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication. Virology 430: 53–62. doi: 10.1016/j.virol.2012.04.019 22608061